Amarpreet Sawhney, President and CEO at OCULAR THERAPEUTIX, INC (OCUL), bought 45,300 shares at $7.85 ($356K) on 2016-12-15, disclosed to the SEC on 2016-12-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OCUL | BUY | 2017-11-20 | $98K | — | Filing → |
| OCUL | BUY | 2016-06-10 | $67K | — | Filing → |
| OCUL | BUY | 2015-11-18 | $83K | — | Filing → |